By proceeding, you agree to our Terms of Use and Privacy Policy.
The World Orphan Drug Congress is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.
The World Orphan Drug Congress is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs & rare diseases meeting.
The congress will bring experts from the whole value chain under one roof, where you get to meet decision makers most applicable for your business.
Gain insights and attend workshops on the development of HEOR & RWE strategies for the commercialization of rare and ultra rare disease products.
Terrapinn events inspire and transform business.We’ve been sparking ideas, innovations and relationships that transform business for over 30 years. Using our global footprint, we bring innovators, disrupters and change agents together.
Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way.
Breakthroughs That Change Patients' Lives: Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives.
At Charles River, we are passionate about our role in improving the quality of people’s lives.
Parexel is focused on the development of innovative new therapies to improve the world’s health.
THREAD’s platform helps unlock the power of your decentralized studies. Sponsors and CROs can remotely capture data from participants and sites during, in between and in lieu of in-clinic visits — securely through one unified platform.
Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront
ICON plc is a global provider of outsourced drug development and commercialisation solutions and services to pharmaceutical, biotechnology, medical device, and government and public health organisations.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry.
Pharma Business Partners is a consulting and market research firm focusing on the life sciences sector. Whilst our experience is global, we focus on MEA related work to add true insights and value to our clients portfolios.
Offering You Peace of Mind to Focus on Your Patients Suvoda’s sole focus is to offer the industry’s leading SaaS solution for randomization and trial supply management.
Since our founding, Caligor Coghlan Pharma Services has been striving to be the premier, global provider of pharma services. Our mission is to deliver high- quality services and access to life enhancing drugs for clients and patients worldwide.
Our mission is to transform the lives of people living with rare diseases and devastating conditions through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services.
Charles River Associates (CRA) is a global consulting firm specializing in litigation, regulatory, financial, and management consulting.
Precision is the first global precision medicine clinical research services organization, purpose-built to improve the clinical research and development process for new therapeutics.
A leading Contract Research Organization (CRO) designed to navigate the complexity of trials in orphan indications.
Aparito is a global health tech company that brings clinical trials to patients and unlocks real-world data through mobile apps, video assessments & wearable devices.
We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society.
myTomorrows is a platform that helps patients and physicians discover and access treatments in development.
Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. The company is purpose-built through the convergence of leading providers to address this unmet need.
Optimized decision planning to accelerate patient access to health innovations.
Clinigen has more than 30 years’ experience providing quicker and broader access to critical medicines in 120+ countries, pre- and post-launch.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.